U ptake of bowel cancer screening (BCS) is a complex multifactorial problem. This article seeks to outline the current BCS screening modalities. It examines the drivers and barriers to BCS uptake. Finally, it aims to provide practical evidence-based guidance on how best to increase BCS uptake in practice.
U ptake of bowel cancer screening (BCS) is a complex multifactorial problem. This article seeks to outline the current BCS screening modalities. It examines the drivers and barriers to BCS uptake. Finally, it aims to provide practical evidence-based guidance on how best to increase BCS uptake in practice.
The GP curriculum and bowel cancer screening Clinical module 3.13: Digestive health lists the learning objectives required for a GP to manage digestive heath in the community. In particular GPs are expected to: . Be aware of the many issues relating to embarrassment and social and cultural factors which influence presentation to primary care, and how you can have a constructive approach to these
. Understand the many cultural and social factors which can influence the way patients interpret symptoms and the manner in which this influences their expectations of medical management
. Be able to identify patients' attitudes and beliefs about digestive symptoms and disease, and how they might influence patterns of presentation . Understand the dynamics for screening for colorectal cancer and its influence on individual patient management . Understand the evidence base for the national guidelines on screening and management of common and important gastrointestinal conditions
. Understand the evidence underpinning the national bowel cancer screening programme, and the public health implications of the programme . Recognise the impact of social and cultural diversity, and the important role of health beliefs relating to diet, nutrition and gastrointestinal function
. Understand screening programmes for colorectal cancer, and the role of primary care in information provision and dealing with symptoms amongst screening invitees
. Understand the high prevalence of gastrointestinal symptoms in the community and the implications for primary care
What is bowel cancer screening?
Bowel cancer is the second-most-common cause of cancer death, after lung cancer: in 2012 around 16 200 people died from colonic malignancy (Cancer Research UK, 2012) . Bowel cancer screening (BCS) is a health maintenance tool of proven efficacy, and has been shown to reduce colorectal cancer mortality by 16% . Screening can detect early signs of bowel cancer, which is often easier to treat successfully (National Cancer Intelligence Network (NCIN), 2010; National Institute for Health and Care Excellence (NICE), 2011) ( Table 1 ). The UK's BCS programme began in 2006.
All patients aged between 60 and 74 years, who are registered with a GP, are sent a screening kit every 2 years. Patients aged over 74 years can request a screening kit by contacting the BCS programme on 0800 707 6060. The UK's BCS currently uses a guaiac faecal occult blood test (gFOBT). Using the sticks provided, patients are asked to apply two smears of faeces, three times, over a 2-week period. The sample is then examined in the laboratory for evidence of colour change and blood. Most participants will receive a normal result (98/100); participants with an abnormal test (2/100) will be invited for a colonoscopy (Public Health England, 2008) . See Fig. 1 .
What are the new tests?

Bowel scope
Bowel scope is a one-off test available to men and women aged 55 years. Following an enema, participants undergo a flexible sigmoidoscopy procedure to look for polyps; they will be awake throughout the examination, and told on the day whether or not they have polyps (NHS, 2018) . See Fig. 2 .
Faecal immunochemical test
The faecal immunochemical test (FIT) is a faecal occult blood test that uses antibodies that specifically recognise human haemoglobin. FIT is scheduled to replace gFOBT in 2018-19. Like the gFOBT, participants with an abnormal FIT test will be invited for colonoscopy.
A meta-analysis comparing FOBT and FIT performed by Mousavinezhad et al. (2016) showed that FIT had higher participation and higher true positive rates than FOBT. FIT had lower rates of false positives and false negatives compared with FOBT (relative risk (RR):-4.06; 95% confidence interval (CI) (-7.89-0.24)). FIT also had a significantly lower number needed to scope (1.6% compared with 2.2%) and number needed to screen (31-49% at different cut off levels) than FOBT. A study by Hol et al. (2009) , which was included in the meta-analysis of Mousavinezhad et al. (2016) , compared both the guaiac and the immunochemical faecal occult blood tests at different cut off levels ( Table 2) .
BCS uptake
For the purposes of this article, uptake is defined as the proportion of people sent a standard bowel cancer screening invitation letter and who return it and receive a definitive result. A non-responder is defined as a person yet to respond to the latest invitation to BCS.
In the 2006 UK BCS pilot, uptake levels were around 60% (NHS, 2003) . As of 2014, in some areas, the uptake was as low as 42% (UK Parliament, 2014) . GP practices receive notification from their local BCS hub whenever their patients complete or fail to complete their kits. Some computer systems automatically code this in the notes; some practices manually code this information. Uptake can be calculated either by running a search of the clinical notes or by using the 'Fingertips' NCIN General Practice Profile available at http://bit.ly/1TRvwud. 'Fingertips' can also provide information about a practice's sociodemographic characteristics.
BCS health inequalities
In areas of socioeconomic deprivation, people are more likely to die from bowel cancer (Cancer Research UK, 2016) , and yet uptake of BCS can be as low as 35% . showed that BCS uptake can be low in ethnically diverse areas (38% compared with 52-58% in other areas) . A study by Floud et al. (2017) showed that women with more than three disabilities, or disabilities related to self-care and vision, were less like to complete screening (RR 0.75 compared with those without disabilities). Osborn et al. (2012) demonstrated that people with learning disabilities are less likely to participate in BCS (RR 0.86) compared with those without learning disabilities. A study by Steele et al. (2010) showed that men from lower socioeconomic groups were not only less likely to complete their BCS kit, but were also most likely to have a positive result.
Why do people not complete their BCS kits?
A method frequently used to explain, predict and influence health behaviours, the Health Belief Model, focuses on specifics of attitudes and beliefs in order to better understand health phenomena, including why some people don't engage with bowel cancer screening (non-respondence) (Wardle et al., 2000) .
Perceived susceptibility and severity
What, in the individual's opinion, is the chance of getting bowel cancer, and how serious are bowel cancer and its consequences? In an interview-based study in 2001 , McCaffery et al. (2003 found that 'low perceived susceptibility to bowel cancer', in terms of current health status, family history, or absence of bowel symptoms, was an important factor in the decision to decline screening. In addition, health literacy was found to be a key determinant of BCS uptake. Health literacy is defined as 'the cognitive and social skills which determine the motivation and ability of individuals to gain access to, understand and use information in ways which promote and maintain good health' (World Health Organization, 2009). Specifically, Kobayashi et al. (2014) found a 10% difference in uptake between 60 and 75 year olds with adequate and inadequate health literacy skills. Von found that patients who were between 50 and 69 years in age and who had a low score on the Test of Functional Health Literacy in Adults were associated with less information-seeking. Current knowledge of other patients' experiences of colonoscopy and early bowel cancer treatment was shown by Chapple et al. (2008) to increase inclination to complete screening.
Perceived benefits
In the individual's opinion, is BCS efficacious in reducing risk or seriousness of impact? Power et al. (2009) found that 'Belief in screening Efficacy' and 'Peace of Mind' (whereby participants are reassured by a negative test) were positively associated with taking part in screening. Both Hall et al. (2015) and Chapple et al. (2008) have suggested that the 'Good Citizen' is another perceived benefit of BCS uptake. Thought to be the product of a socialised health system, 'Good Citizens' try to benefit themselves and society by undergoing screening now, so as to save further expenditure on their care in the future.
Perceived barriers
What, in the individual's opinion, are the tangible and the psychological costs of BCS? The 2011 postal survey by Miles et al. (2011) explored cancer fatalism as a barrier to BCS. Consistent with current literature, it showed that higher cancer fatalism is associated with lower colorectal cancer screening. 'The implications of knowing the screening results' was one of the six general themes, explored in the focus group study performed by Palmer et al. (2014) . It was suggested that fear of a cancer diagnosis and fear of further investigation are barriers to BCS uptake. Further common general attitudinal barriers include 'Embarrassment', 'Lack of time', 'Disgust' and 'Depression'.
Self-efficacy
What factors affect an individual's confidence in their ability to take part in BCS? Several studies, including Chapple et al. (2008) , suggest that participants were concerned about their ability to follow instructions. Participants were also concerned about their ability to complete the BCS kit.
What can GPs do to increase BCS uptake?
A number of interventions will increase BCS uptake (Table 3) ; a definitive list, with practical tips on increasing uptake can be found on www.cancerresearchuk.org/health-professional/ screening/bowel-screening-evidence-and-resources/bowelscreening-resources. 
GP endorsement letter
GP endorsement has been shown to increase uptake of BCS. A study by Hewitson et al. (2011) showed that a GP endorsement letter, sent along with the BCS kit increased uptake by 6%. Uptake was increased by 12% with the combination of GP endorsement letter and enhanced patient information leaflet (Cole et al., 2002) . More recently, a study performed by Raine et al. (2016) further demonstrated the impact of GP endorsement on BCS uptake. The study, involving 80% of the GP practices in England, added a simple GP endorsement banner to the BCS screening letter. This intervention was shown to increase BCS uptake by 0.7%.
Patient leaflet
Patient education leaflets have been shown to increase BCS uptake. A study by Hewitson et al. (2011) demonstrated that sending an enhanced leaflet with the BCS kit increased uptake by 6%. Cameron et al. (2011) showed an increase in uptake of 6.1% when a leaflet was sent in combination with a DVD and a reminder letter; Shankaran et al. (2007) found that BCS uptake increased by 12% when a leaflet was combined with a brochure and a reminder letter.
Telephone
Telephone calls have been shown to increase BCS uptake. A UK study by Shankleman et al. (2014) , in which participants were called to offer information and answer questions about BCS, in addition to a GP endorsement letter, showed an increase in uptake of 8%. This study demonstrated that a telephone call was effective in an ethnically diverse population in an area of deprivation. A study of colorectal cancer screening in an ethnically diverse population in New York performed by Basch et al. (2006) showed that uptake was significantly increased by telephone contact, in comparison with normal mailshots.
Reminder letter
The ASCEND study in 2016, performed by Wardle et al. (2016) examined the impact of multiple interventions on uptake of BCS, and examined the differences in uptake over a socioeconomic gradient. In trial 4, BCS non-responders were sent a reminder letter. The reminder letter increased overall uptake (odds ratio (OD) 1.07, CI 1.03 -1.11, p ¼ 0.001). The reminder letter was also found to have a stronger effect in the most deprived quintile (adjusted OR 1.11, 95% CI 1.04 -1.20, p ¼ 0.003).
KEY POINTS
. Bowel cancer is the second-most-common cause of cancer death, after lung cancer; in 2012 around 16 200 people died from colonic malignancy
. BCS is an intervention of proven efficacy, but current uptake is lower than the pilot study
. Uptake is lowest in lower socioeconomic quintiles, areas of ethnic diversity and among men
. Common barriers to BCS uptake include: low health literacy, embarrassment and low self-efficacy
. A GP endorsement letter, plus leaflet, has been shown to have the biggest impact on BCS uptake
. Additional methods include leaflets, telephone calls and reminder letters; these have also been shown to increase uptake
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